Abstract
Introduction
Postoperative pancreatic fistula (POPF) is one of the major critical complications after pancreatic resection. Recently, postoperative acute pancreatitis (POAP), a new concept for a pancreatic-specific complication following pancreatic resection, has been advocated, and its association with POPF has been reported. The present study examined the clinical features of POAP and identified the associations of POAP with POPF and other postoperative morbidities in pancreatic ductal adenocarcinoma (PDAC) patients undergoing pancreatic resection.
Methods
A total of 312 consecutive patients who underwent pancreatic resection for PDAC at our institution from 2013 to 2019 were enrolled in this study. POAP was defined as an elevated serum amylase level above the upper limit normal on postoperative day (POD) 0 or 1, based on Connor’s definition. The severity of POPF was assessed by the International Study Group on Pancreatic Surgery definition.
Results
A total of 184 patients (58.9%) had POAP. POAP occurred in 58.5% of subtotal stomach-preserving pancreatoduodenectomy patients and 60% of distal pancreatectomy combined with splenectomy patients. The presence of POAP was significantly associated with the development of clinically relevant POPF, higher rates of severe morbidity, and a prolonged hospital stay after pancreatic resection. A multivariate analysis showed that the presence of POAP and elevated C-reactive protein levels on POD 3 were independent predictors of clinically relevant POPF after subtotal stomach-preserving pancreatoduodenectomy.
Conclusions
POAP is associated with the development of POPF, higher rates of severe morbidity, and a prolonged hospital stay after pancreatic resection and is an independent risk factor for clinically relevant POPF after pancreatoduodenectomy. POAP represents an important indicator for planning treatment strategies to prevent serious complications, including POPF.
Similar content being viewed by others
References
Lai EC, Lau SH, Lau WY (2009) Measures to prevent pancreatic fistula after pancreatoduodenectomy: a comprehensive review. Arch Surg 144(11):1074–1080. https://doi.org/10.1001/archsurg.2009.193
Lermite E, Pessaux P, Brehant et al (2007) Risk factors of pancreatic fistula and delayed gastric emptying after pancreaticoduodenectomy with pancreaticogastrostomy. J Am Coll Surg, 204(4), 588-596. https://doi.org/10.1016/j.jamcollsurg.2007.01.018
Shrikhande SV, D’Souza MA (2008) Pancreatic fistula after pancreatectomy: evolving definitions, preventive strategies and modern management. World J Gastroenterol 14(38):5789–5796. https://doi.org/10.3748/wjg.14.5789
Callery MP, Pratt WB, Kent TS et al (2013) A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg 216(1):1–14. https://doi.org/10.1016/j.jamcollsurg.2012.09.002
McMillan MT, Soi S, Asbun HJ et al (2016) Risk-adjusted outcomes of clinically relevant pancreatic fistula following pancreatoduodenectomy: a model for performance evaluation. Ann Surg 264(2):344–352. https://doi.org/10.1097/SLA.0000000000001537
Connor S (2016) Defining post-operative pancreatitis as a new pancreatic specific complication following pancreatic resection. HPB (Oxford) 18(8):642–651. https://doi.org/10.1016/j.hpb.2016.05.006
Cuthbertson CM, Christophi C (2006) Disturbances of the microcirculation in acute pancreatitis. Br J Surg 93(5):518–530. https://doi.org/10.1002/bjs.5316
Gasteiger S, Primavesi F, Göbel G et al (2020) Early post-operative pancreatitis and systemic inflammatory response assessed by serum lipase and IL-6 predict pancreatic fistula. World J Surg 44(12):4236–4244. https://doi.org/10.1007/s00268-020-05768-9
Wüster C, Shi H, Kühlbrey CM et al (2020) Pancreatic inflammation and proenzyme activation are associated with clinically relevant postoperative pancreatic fistulas after pancreas resection. Ann Surg 272(5):863–870. https://doi.org/10.1097/sla.0000000000004257
Andrianello S, Bannone E, Marchegiani G et al (2021) Characterization of postoperative acute pancreatitis (POAP) after distal pancreatectomy. Surgery 169(4):724–731. https://doi.org/10.1016/j.surg.2020.09.008
Palani Velu LK, Chandrabalan VV, Jabbar S et al (2014) Serum amylase on the night of surgery predicts clinically significant pancreatic fistula after pancreaticoduodenectomy. HPB (Oxford) 16(7):610–619. https://doi.org/10.1111/hpb.12184
Cloyd JM, Kastenberg ZJ, Visser BC et al (2014) Postoperative serum amylase predicts pancreatic fistula formation following pancreaticoduodenectomy. J Gastrointest Surg 18(2):348–353. https://doi.org/10.1007/s11605-013-2293-3
Palani Velu LK, McKay CJ, Carter CR et al (2016) Serum amylase and C-reactive protein in risk stratification of pancreas-specific complications after pancreaticoduodenectomy. Br J Surg 103(5):553–563. https://doi.org/10.1002/bjs.10098
Bannone E, Andrianello S, Marchegiani G et al (2018) Postoperative acute pancreatitis following pancreaticoduodenectomy: a determinant of fistula potentially driven by the intraoperative fluid management. Ann Surg 268(5):815–822. https://doi.org/10.1097/SLA.0000000000002900
Tol JA, Gouma DJ, Bassi C et al (2014) Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS). Surgery 156(3):591–600. https://doi.org/10.1016/j.surg.2014.06.016
Dillhoff M, Pawlik TM (2021) Role of node dissection in pancreatic tumor resection. Ann Surg Oncol 28(4):2374–2381. https://doi.org/10.1245/s10434-020-09394-6
Kakita A, Takahashi T, Yoshida M et al (1996) A simpler and more reliable technique of pancreatojejunal anastomosis. Surg Today 26(7):532–535. https://doi.org/10.1007/bf00311562
Katayama H, Kurokawa Y, Nakamura K et al (2016) Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today 46(6):668–685. https://doi.org/10.1007/s00595-015-1236-x
Bassi C, Marchegiani G, Dervenis C et al (2017) The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery 161(3):584–591. https://doi.org/10.1016/j.surg.2016.11.014
Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 48(3):452–458. https://doi.org/10.1038/bmt.2012.244
Kuhlbrey CM, Samiei N, Sick O et al (2017) Pancreatitis after pancreatoduodenectomy predicts clinically relevant postoperative pancreatic fistula. J Gastrointest Surg 21(2):330–338. https://doi.org/10.1007/s11605-016-3305-x
Ikenaga N, Ohtsuka T, Nakata K et al (2020) Clinical significance of postoperative acute pancreatitis after pancreatoduodenectomy and distal pancreatectomy. Surgery. https://doi.org/10.1016/j.surg.2020.06.040
Loos M, Strobel O, Mehrabi A et al (2021) Postoperative acute pancreatitis is a serious but rare complication after distal pancreatectomy. HPB (Oxford). https://doi.org/10.1016/j.hpb.2021.01.004
Crippa S, Salvia R, Falconi M et al (2007) Anastomotic leakage in pancreatic surgery. HPB (Oxford) 9(1):8–15. https://doi.org/10.1080/13651820600641357
Subar D, Pietrasz D, Fuks D et al (2015) A novel technique for reducing pancreatic fistulas after pancreaticojejunostomy. J Surg Case Rep, 2015(7). https://doi.org/10.1093/jscr/rjv074
Birgin E, Reeg A, Teoule P et al (2019) Early postoperative pancreatitis following pancreaticoduodenectomy: what is clinically relevant postoperative pancreatitis? HPB (Oxford) 21(8):972–980
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Conflict of interest
Yasushi Rino has received research grants from Taiho pharmaceutical, Abbott, Asahi Kasei, Zeria pharmaceutical, Daiichi-Sankyo, Tsumura & Co., Covidien, and Otsuka. Satoshi Kobayashi has received a speaker honorarium from Bayer Yakuhin, Taiho Pharmaceutical, Yakult Honsha, Eisai, Eli Lilly, Takeda Pharmaceutical, and Chugai Pharmaceutical. Masaaki Murakawa declares that he has no conflict of interest. Yuto Kamioka declares that he has no conflict of interest. Shinnosuke Kawahara declares that he has no conflict of interest. Naoto Yamamoto declares that he has no conflict of interest. Makoto Ueno declares that he has no conflict of interest. Manabu Morimoto declares that he has no conflict of interest. Hiroshi Tamagawa declares that he has no conflict of interest. Takashi Ohshima declares that he has no conflict of interest. Norio Yukawa declares that he has no conflict of interest. Munetaka Masuda declares that he has no conflict of interest. Soichiro Morinaga declares that he has no conflict of interest.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Murakawa, M., Kamioka, Y., Kawahara, S. et al. Postoperative acute pancreatitis after pancreatic resection in patients with pancreatic ductal adenocarcinoma. Langenbecks Arch Surg 407, 1525–1535 (2022). https://doi.org/10.1007/s00423-022-02481-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-022-02481-0